[1]
|
Colagrande, S., Inghilesi, A.L., Aburas, S., et al. (2016) Challenges of Advanced Hepatocellular Carcinoma. World Journal of Gastroenterology, 22, 7645-7659. https://doi.org/10.3748/wjg.v22.i34.7645
|
[2]
|
Qi, J., Wang, J., Katayama, H., Sen, S. and Liu, S.M. (2013) Circulating MicroRNAs (cmiRNAs) as Novel Potential Biomarkers for Hepatocellular Carcinoma. Neoplasma, 60, 135-142. https://doi.org/10.4149/neo_2013_018
|
[3]
|
Bray, F., et al. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 1-31. https://doi.org/10.3322/caac.21492
|
[4]
|
EI-Serag, H.B. (2011) Hepatocellular Carcinoma. New England Journal of Medicine, 365, 1118-1127.
https://doi.org/10.1056/NEJMra1001683
|
[5]
|
Huang, J.-T., et al. (2016) Systematic Review and Meta-Analysis: Circulating MiRNAs for Diagnosis of Hepatocellular Carcinoma. Journal of Cellular Physiology, 231, 328-335. https://doi.org/10.1002/jcp.25135
|
[6]
|
常莹, 何星星, 黎培员, 等. Mi R-122调控肝癌遗传印迹基因PEGIO的实验研究[J]. 中华肝脏病杂志, 2010, 18(4): 288-291.
|
[7]
|
蒋永容, 陈川, 张志敏, 等. mi RNA.122a靶基因预测及生物信息学分析[J]. 中国肿瘤I临床, 2011, 38(16): 931-934.
|
[8]
|
Xu, Y., Xia, F., Ma, L., et a1. (2011) Mi-croRNA-122 Sensitizes HCC Cancer Cells to Adriamycin and Vineristine through Modulating Expression of MDR and Inducing Cell Cycle Arrest. Cancer Letters, 310, 160-169.
|
[9]
|
张缨, 贾绍昌, 项方, 等. miR-122在肝癌细胞中的表达及其与细胞周期调控的关系[J]. 临床肿瘤学杂志, 2013, 18(8): 691-694.
|
[10]
|
张缨, 贾绍昌, 项方, 等. miR-21在肝癌细胞中的表达及其与抑癌基因PTEN的关系[J]. 临床肿瘤学杂志, 2014, 19(6): 490-493.
|
[11]
|
Michell, P.S., Parkin, R.K., Kroh, E.N., et al. (2008) Circulating MicroRNAs as Stable Blood-Based Markers for Cancer Detection. Proceedings of the National Academy of Sciences of USA, 105, 10513-10518.
https://doi.org/10.1073/pnas.0804549105
|
[12]
|
马京香, 宫奇林, 林梅青, 等. 多项肿瘤标志物联合检测早期诊断原发性肝癌的研究[J]. 中华外科杂志, 2000, 38(1): 14-16.
|
[13]
|
Bai, S., Nasser, M.W., Wang, B., et al. (2009) Micro RNA-122 Inhibits Tumorigenic Properties of Hepatocellular Carcinoma Cells and Sensitizes These Cells to So-rafenib. The Journal of Biological Chemistry, 284, 32015-32027.
https://doi.org/10.1074/jbc.M109.016774
|
[14]
|
Ma, L., Liu, J., Shen, J., et al. (2010) Expression of mi R-122 Me-diated by Adenoviral Vector Induces Apoptosis and Cell Cycle Arrest of Cancer Cells. Cancer Biology & Therapy, 9, 554-561. https://doi.org/10.4161/cbt.9.7.11267
|
[15]
|
Zhou, J., Yu, L., Gao, X., et al. (2011) Plasma Micro RNA Panel to Diagnose Hepatitis B Virus Related Hepatocellular Carcinoma. Journal of Clinical Oncology, 29, 478l-4788. https://doi.org/10.1200/JCO.2011.38.2697
|
[16]
|
赵敏, 李贵柱, 邹强, 等. 肝癌组织miR-122的表达及其与细胞周期调控的关系[J]. 临床肿瘤学杂志, 2010, 15(5): 406-408.
|
[17]
|
Wang, K.R., Yan, J.X., Zhang, B.Z., et al. (2009) Novel Mode of Action of Polybia MPI, a Novel Antimicrobial Peptide, in Multi-Drug Resist-Ant Leukenic Cells. Cancer Letters, 278, 65-72. https://doi.org/10.1016/j.canlet.2008.12.027
|
[18]
|
Coulouaru, C., Factor, V.M., Andersen, J.B., et al. (2009) Loss of miR-122 Expression in Liver Cancer Correlates with Suppression of the Hepat-ic-Phenotype and Gain of Metastatic Properties. Oncogene, 28, 3526-3536.
|
[19]
|
Foruan, F., Gramantieri, L., Giovannini, C., et al. (2009) MiR122/cyclinG1 Interaction Modulates p53 Activity and Affects Doxorubicin Sensitivity of Human Hepatocarcinoma Cells. Cancer Research, 69, 5761-5767.
https://doi.org/10.1158/0008-5472.CAN-08-4797
|
[20]
|
Krichevsky, A.M. and Gabriely, G. (2009) MiR-21: A Small Multi-Faceted RNA. Journal of Cellular and Molecular Medicine, 13, 39-53. https://doi.org/10.1111/j.1582-4934.2008.00556.x
|
[21]
|
Meng, F., Henson, R., Wehbe-Janek, H., et al. (2007) Micro RNA-21 Regulates Expression of the PTEN Tumor Suppressor Gene in Human Hepatocellular Cancer. Gastroenterology, 133, 647-658.
https://doi.org/10.1053/j.gastro.2007.05.022
|
[22]
|
Connolly, E., Melegari, M., Landgraf, P., et al. (2008) Elevated Expression of the miR-17-92 Polycistron and miR-21 in Hepadnavirus-Associated Hepato-Cellular Carcinoma Contributes to the Malignant Phenotype. The American Journal of Pathology, 173, 856-864. https://doi.org/10.2353/ajpath.2008.080096
|
[23]
|
王兴, 张娟, 夏宁, 等. 血清miR-21及AFP在大鼠肝癌发生过程中的动态表达比较分析[J]. 现代生物医学进展, 2012, 12(12): 2282-2297.
|
[24]
|
Guo, X., Lv, X., Lv, X., et al. (2017) Circulating miR-21 Serves as a Serum Biomarker for Hepatocellular Carcinoma and Correlated with Distant Metastasis. Oncotarget, 8, 44050-44058.
|
[25]
|
姜英丽, 陈虹. 肝癌早期诊断标志物的研究进展[J]. 中国医学工程, 2011(4): 169-170.
|
[26]
|
Song, K., Hyunjoo, K., Han, C., et al. (2015) Active Glycolytic Metabolism in CD133+ Hepatocellular Cancer Stem Cells: Regulation by miR-122. Oncotarget, 6, 40822-40835.
|